Companies: 10,795·Total market cap: $144.5T

Axcella Health Inc.

Axcella Health Inc.

AXLANASDAQHealthcare

$4.58

+$0.00(+0.00%)

Market Cap$12503400

P/E Ratio—

52W High$4.58

52W Low$4.58

Avg Volume37K

Open$0.36

Beta0.57

股票排行：Biotechnology·Healthcare·查看全部市值排行 →

Axcella Health Inc.（AXLA）股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · AXLA · 截至 Jun 9, 2026

关键指标

EPS (TTM)$-2.10Earnings history

PE Ratio (TTM)—PE Ratio deep dive

Revenue (TTM)0.00Full revenue history

Dividend Yield不分红Dividend history

Shares Outstanding64.0MShares outstanding history

Next EarningsTBAEarnings history

探索 Axcella Health Inc. 数据

分析师预测$60 · Buy

股息不分红

盈利EPS $-1.27+27.84%

财务快照

FY 2022Revenue$0.00

202020212022

FY 2022Net Income-$81.2M▼ 20.96% YoY

202020212022

FY 2022EPS$-1.27▲ +27.84% YoY

202020212022

TTM:Revenue: $0.00Net Income: -$50.0MEPS: $-2.10View income statement →

分析师评级与目标价

Buy10 位分析师

Strong Buy

0

Buy

6

Hold

3

Sell

1

Strong Sell

0

12-Month Price Target

$60.00Low

$4.58Current

$60.00Avg Target上涨空间 1210.04%

$60.00High

合计: 10 · 买入占比: 60.0%

根据过去 3 个月内 10 位华尔街分析师，AXLA 共识评级为 Buy，12 个月平均目标价 $60.00 （较现价 $4.58 上涨空间 1210.04%）。

竞争对手与同行

#TickerCompanyPriceChangeMkt Cap

Axcella Health Inc.

$4.58+0.00%$12.5M #2

Applied Molecular Transport Inc.

$0.26-3.13%$11.0M #3

Celyad Oncology S.A.

$0.47-12.96%$14.2M #4

Gelesis Holdings, Inc.

$0.16+0.00%$11.6M #5

TuHURA Biosciences, Inc.

$2.05+4.07%$130.2M #6

Korro Bio, Inc.

$10.59-1.21%$105.4M

股票表现

1D+0.00%

1W+0.00%

1M+0.00%

3M+0.00%

YTD+0.00%

1Y+0.00%

5Y-96.03%

关于 Axcella Health Inc.

CEOCraig R. Jalbert CIRA

IPO DateMay 9, 2019

Employees11

CountryUS

Websiteaxcellahealth.com

Axcella Health Inc. is a U.S.-based clinical-stage biotechnology firm focused on developing novel therapeutic compositions derived from endogenous metabolic modulators. These aim to address complex di…

Biotechnology HealthcareNASDAQUS

关于股票概览与关键数据

Axcella Health Inc.（AXLA）是 Biotechnology 行业的 Healthcare 类公司，于 May 9, 2019 在 NASDAQ 上市。截至最近交易日，AXLA 股价为 $4.58，市值约为 $12.5M。过去12个月累计回报 +0.00%，年初至今回报 +0.00%。

根据 10 位华尔街分析师，Axcella Health Inc. 股票共识评级为Buy，12个月平均目标价为 $60.00。2022 财年 Axcella Health Inc. 营收 —，净利润 -$81.2M。更多数据（营收历史、盈利、股息、市盈率）请使用上方标签页。

常见问题

截至最近一个交易日，Axcella Health Inc.（AXLA）股价为 $4.58，在 NASDAQ 上市，52周区间为 $4.58 – $4.58。

AXLA 最新股价AXLA quote todaylive ticker 实时行情

数据来源：Financial Modeling Prep最后更新：Jun 9, 2026本内容不构成投资建议